Open AccessA 18F-FDG PET/CT screening study of a hepatocellular carcinoma patient with diffuse 18F-FDG uptake into the portal vein and its intrahepatic branches
Author(s) -
Reyhan Köroğlu,
İsmail Türker Köksal,
Fatma Gezer,
Ayşegül Sağır Kahraman,
Ersoy Kekilli
Publication year - 2016
Publication title -
world journal of nuclear medicine
Language(s) - English
Resource type - Journals
eISSN - 1607-3312
pISSN - 1450-1147
DOI - 10.4103/1450-1147.167590
Subject(s) - medicine , hepatocellular carcinoma , radiology , magnetic resonance imaging , portal vein , positron emission tomography , intrahepatic cholangiocarcinoma , liver transplantation , biopsy , nuclear medicine , metastasis , transplantation , cancer , pathology
Major vascular invasion is one of the worst prognostic factors of hepatocellular carcinoma (HCC). Fludeoxyglucose F 18 ((18) F-FDG) positron emission tomography/computed tomography (PET/CT) method is succesfully being used in HCC patients for the detection of particularly long-distance metastasis. Major vascular invasion is shown by radiological methods [particularly dynamic CT and/or magnetic resonance imaging (MRI)]. A male patient aged 60 years was diagnosed with HCC, according to biopsy after the detection of a mass in the liver. His medical examinations that were performed for the evaluation in terms of liver transplantation were dynamic CT and dynamic MRI; invasion in the intrahepatic branches of the portal vein and in main portal vein was also detected. PET/CT was performed to investigate the distant metastases. Moreover, diffuse (18) F-FDG uptake in the intrahepatic branches of the portal vein and in the main portal vein was observed.